MacroGenics Inc MGNX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 04/12/21 EDT
30.07UNCH (UNCH)
Volume
3,964
Close
30.07quote price arrow down-1.09 (-3.50%)
Volume
1,270,562
52 week range
5.00 - 33.61

...

Loading . . .
  • Open31.30
  • Day High31.47
  • Day Low29.90
  • Prev Close30.07
  • 52 Week High33.61
  • 52 Week High Date04/06/21
  • 52 Week Low5.00
  • 52 Week Low Date04/16/20

Key Stats

  • Market Cap1.803B
  • Shares Out59.97M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta2.27
  • YTD % Change31.54

KEY STATS

  • Open31.30
  • Day High31.47
  • Day Low29.90
  • Prev Close30.07
  • 52 Week High33.61
  • 52 Week High Date04/06/21
  • 52 Week Low5.00
  • 52 Week Low Date04/16/20
  • Market Cap1.803B
  • Shares Out59.97M
  • 10 Day Average Volume0.51M
  • Dividend-
  • Dividend Yield-
  • Beta2.27
  • YTD % Change31.54

RATIOS/PROFITABILITY

  • EPS (TTM)-2.55
  • P/E (TTM)-11.80
  • Fwd P/E (NTM)-17.54
  • EBITDA (MRQ)-119.06M
  • ROE (MRQ)-49.28%
  • Revenue (MRQ)104.88M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-123.70%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From MacroGenics Inc

There is no recent news for this security.

Profile

MORE
MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company develops therapeutic product candidates using its antibody-based technology platforms and also in collaboration with other biopharmaceutical companies. It has a pipeline of product candidates in human clinical testing, primarily as...
Paulo Costa
Chairman
Scott Koenig M.D. Ph.D.
President
James Karrels
Chief Financial Officer
Jeffrey Peters
Vice President
Lynn Cilinski
Vice President
Address
9704 Medical Center Dr
Rockville, MD
20850-3343
United States

Top Peers

SYMBOLLASTCHG%CHG
NGM
NGM Biopharmaceuticals Inc
24.53-0.90-3.54%
SGMO
Sangamo Therapeutics Inc
11.06+0.04+0.36%
HRTX
Heron Therapeutics Inc
16.29-0.31-1.87%
CYTK
Cytokinetics Inc
23.85-0.31-1.28%
PGEN
Precigen Inc
6.83-0.20-2.85%